+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
Pediatric Neuroblastoma Treatment Market Report 2025 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Myasthenia Gravis Treatment Market: Forecast and Trends - Product Thumbnail Image

Myasthenia Gravis Treatment Market: Forecast and Trends

  • Report
  • November 2023
  • 120 Pages
  • Global
From
From
From
Allergy Relieving Eye Drops Market 2024-2028 - Product Thumbnail Image

Allergy Relieving Eye Drops Market 2024-2028

  • Report
  • August 2024
  • 141 Pages
  • Global
From
Vitiligo Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Vitiligo Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 192 Pages
  • Global
From
Atopic Dermatitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Atopic Dermatitis Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 179 Pages
  • Global
From
From
From
From
Ovulation Inducing Drugs Market Report 2025 - Product Thumbnail Image

Ovulation Inducing Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Loading Indicator